On Wednesday, Evertec Inc (NYSE:EVTC)’s shares inclined 1.01% to $18.04.
EVERTEC, Inc. (EVTC) declared that its operating partner, EVERTEC Group, LLC, reached a contract on August 28, 2015 to purchase 65% of the share capital of Processa S.A.S., a Colombian company that is based in Bogotá and engaged in the business of payment processing and supply of related services and equipment in Colombia. The aggregate purchase price for the shares equals about COP 16,728 million, or about US$5.4 million at current exchange rates, and is subject to customary adjustments.
The transaction is subject to customary closing conditions, counting receipt of US federal bank regulatory approval. The transaction is subject to customary termination provisions, counting the right of either EVERTEC or the selling shareholders to terminate the transaction if it has not closed within three months after signing of the share purchase agreement. Receipt of US federal bank regulatory approval is dependent on factors outside the control of EVERTEC. There is no assurance that such approval will be obtained within three months after signing of the share purchase agreement or at all.
EVERTEC, Inc. provides various transaction processing services to financial institutions, merchants, corporations, and government agencies in Latin America and the Caribbean. The company operates in three segments: Merchant Acquiring, Payment Processing, and Business Solutions.
Arbutus Biopharma Corp (NASDAQ:ABUS)’s shares gained 3.40% to $6.99.
Arbutus Biopharma Corporation (ABUS), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV), recently declared the initiation of dosing in the 20 subject expansion cohort of the TKM-PLK1 hepatocellular carcinoma (HCC) Phase IIa clinical study. This study is designed to evaluate TKM-PLK1’s safety and efficacy in treating HCC patients.
Arbutus Biopharma Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics, and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. The company’s products for Hepatitis B virus (HBV) comprise TKM-HBV, a RNAi therapeutic in Phase I clinical trial; OCB-030, a cyclophilin inhibitor drug candidate; CYT-003, a TLR9 agonist; capsid assembly inhibitors for use as oral therapeutics; surface antigen secretion inhibitors; STING agonists, a stimulator of interferon genes research program; cccDNA formation inhibitors for reducing the amount of cccDNA in the infected liver cell; and cccDNA epigenetic modifiers, a research program to inhibit the formation of new virus and subviral particles from cccDNA.
At the end of Wednesday’s trade, RSP Permian Inc (NYSE:RSPP)‘s shares surged 2.91% to $23.72.
RSP Permian, Inc. (“RSP” or the “Company”) (RSPP) has closed its formerly declared bolt-on acquisitions in the Company’s existing core operating areas in the Midland Basin for an aggregate purchase price of about $274 million in cash, subject to certain post-closing adjustments. As formerly revealed, the acquisitions comprise 5,704 net surface acres, or 27,287 net effective horizontal acres, in the Midland Basin with 162 net horizontal drilling locations in five zones (Middle Spraberry, Lower Spraberry, Wolfcamp A, Wolfcamp B and Wolfcamp D (Cline)). The attained properties comprise over 85 million Boe of resource potential based on internal estimates, are 100% operated by RSP, are 100% held by production and have an average royalty burden of only 23%.
Substantially concurrent with the closing of the acquisitions, RSP closed an amendment with the lenders under its revolving credit facility that, among other things, enhances the borrowing base 20% to $600 million. The Company presently has no amounts drawn under its revolving credit facility and the next planned borrowing base redetermination is May 1, 2016.
RSP Permian, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, development, and production of unconventional oil and associated liquids-rich natural gas reserves in the Permian Basin of West Texas. It owns interest in contiguous acreage blocks in the core of the Midland Basin, a sub-basin of the Permian Basin, primarily in the adjacent counties of Midland, Martin, Andrews, Dawson, Ector, and Glasscock.
Apollo Education Group Inc (NASDAQ:APOL), ended its Wednesday’s trading session with 1.20% gain, and closed at $10.94.
University of Phoenix® School of Business and the U.S. Black Chambers, Inc. (USBC) declared a new educational training program for USBC members and African-American small business owners. The USBC Step Up Entrepreneurs Program, powered by University of Phoenix, comprises a three-course, 15-week credit-bearing component that comprises online classroom instruction taught by University of Phoenix School of Business faculty, and takes students through courses counting personal cash flow, market analyses and financial performance.
Students will create their business plans following completion of the courses to develop a business model, strategy, financial forecasts, competition benchmarks and implementation and performance tracking. Starting in January 2016, the program will start in five major cities throughout USBC’s regions across the country and is backed by a $500,000 grant from University of Phoenix.
At the start of each course, participants are encouraged to attend an in-person micro operateshop with a local USBC expert on topics such as accounting and finance, marketing, operations and customer service. A key component of this opportunity comprises the creation of a feasibility plan that can be presented for either a traditional bank or micro plan partner. Students who complete the courses will earn nine hours of college credit, which can be applied towards a certificate or degree program at University of Phoenix.
Apollo Education Group, Inc. provides private education services. It offers online and on-campus undergraduate, graduate, professional development, and other non-degree educational programs and services primarily to working learners in the United States and internationally. The company operates in University of Phoenix, Apollo Global, and Other segments. It offers various degree programs in advanced studies, business, criminal justice and security, education, health sciences and nursing, humanities and sciences, information systems and technology, and social sciences.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
